Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 3
1948 1
1951 1
1956 5
1957 3
1958 2
1960 1
1964 1
1966 4
1967 3
1968 1
1969 3
1970 1
1973 2
1974 1
1975 1
1976 2
1979 4
1980 4
1981 3
1982 2
1983 2
1984 9
1985 10
1986 7
1987 7
1988 10
1989 12
1990 7
1991 17
1992 16
1993 20
1994 20
1995 10
1996 14
1997 9
1998 16
1999 8
2000 7
2001 9
2002 11
2003 12
2004 16
2005 13
2006 18
2007 24
2008 19
2009 29
2010 30
2011 25
2012 26
2013 27
2014 34
2015 23
2016 21
2017 43
2018 53
2019 50
2020 65
2021 55
2022 47
2023 37
2024 43
2025 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

903 results

Results by year

Filters applied: . Clear all
Page 1
Editorial. Preface.
Hobbs M. Hobbs M. Perspect Public Health. 2021 Sep;141(5):246. doi: 10.1177/17579139211036341. Perspect Public Health. 2021. PMID: 34431393 No abstract available.
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
Zanwar S, Ho M, Lin Y, Kapoor P, Binder M, Buadi FK, Dispenzieri A, Dingli D, Fonder A, Gertz MA, Gonsalves W, Hayman SR, Hwa Y, Hobbs M, Kourelis T, Lacy MQ, Leung N, Muchtar E, Warsame R, Jevremovic D, Kyle RA, Rajkumar SV, Kumar S. Zanwar S, et al. Among authors: hobbs m. Am J Hematol. 2023 Oct;98(10):1540-1549. doi: 10.1002/ajh.27023. Epub 2023 Jul 8. Am J Hematol. 2023. PMID: 37421603 Free article.
Value of bone marrow examination in determining response to therapy in patients with multiple myeloma in the context of mass spectrometry-based M-protein assessment.
Claveau JS, Murray DL, Dispenzieri A, Kapoor P, Binder M, Buadi F, Dingli D, Fonder A, Gertz M, Gonsalves W, Hayman S, Hobbs M, Hwa YL, Kourelis T, Lacy M, Leung N, Lin Y, Warsame R, Kyle RA, Rajkumar V, Kumar SK. Claveau JS, et al. Among authors: hobbs m. Leukemia. 2023 Jan;37(1):1-4. doi: 10.1038/s41375-022-01779-8. Epub 2022 Dec 8. Leukemia. 2023. PMID: 36482129 No abstract available.
Retreatment of multiple myeloma with previously refractory drugs.
Goel U, Charalampous C, Kapoor P, Binder M, Buadi FK, Dingli D, Dispenzieri A, Fonder A, Gertz MA, Gonsalves WI, Hayman SR, Hobbs MA, Hwa YL, Kourelis T, Lacy MQ, Leung N, Lin Y, Warsame RM, Kyle RA, Rajkumar SV, Kumar SK. Goel U, et al. Among authors: hobbs ma. Blood Adv. 2024 Dec 24;8(24):6321-6328. doi: 10.1182/bloodadvances.2024014723. Blood Adv. 2024. PMID: 39536293 Free PMC article.
Improved survival with daratumumab-CyBorD compared with CyBorD as frontline therapy for AL amyloidosis.
Yohannan B, Rees M, Gertz MA, Dispenzieri A, Kapoor P, Buadi FK, Dingli D, Leung N, Lacy MQ, Hayman SR, Gonsalves W, Kourelis T, Cook J, Binder M, Siddiqui M, Lin Y, Hwa L, Rogers MG, Hobbs M, Fonder A, Warsame R, Rajkumar SV, Kumar SK, Muchtar E. Yohannan B, et al. Among authors: hobbs m. Blood Neoplasia. 2025 Mar 10;2(2):100092. doi: 10.1016/j.bneo.2025.100092. eCollection 2025 May. Blood Neoplasia. 2025. PMID: 40453144 Free PMC article. Clinical Trial.
Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.
Bolarinwa A, Nagaraj M, Zanwar S, Abdallah N, Bergsagel PL, Binder M, Buadi F, Chhabra S, Cook J, Dingli D, Dispenzieri A, Gertz MA, Gonsalves W, Hayman S, Kapoor P, Kourelis T, Leung N, Lin Y, Muchtar E, Parrondo R, Roy V, Sher T, Siddiqui M, Warsame R, Fonder A, Hobbs M, Hwa YL, Rogers M, Yadav U, Wiedmeier-Nutor JE, Baughn LB, Vincent Rajkumar S, Fonseca R, Ailawadhi S, Kumar S. Bolarinwa A, et al. Among authors: hobbs m. Blood Cancer J. 2025 Apr 4;15(1):57. doi: 10.1038/s41408-025-01264-2. Blood Cancer J. 2025. PMID: 40185701 Free PMC article.
Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment.
Butler PM, Yang J, Brown R, Hobbs M, Becker A, Penalver-Andres J, Syz P, Muller S, Cosne G, Juraver A, Song HH, Saha-Chaudhuri P, Roggen D, Scotland A, Silveira N, Demircioglu G, Gabelle A, Hughes R, Erkkinen MG, Langbaum JB, Lingler JH, Price P, Quiroz YT, Sha SJ, Sliwinski M, Porsteinsson AP, Au R, Bianchi MT, Lenyoun H, Pham H, Patel M, Belachew S. Butler PM, et al. Among authors: hobbs m. Nat Med. 2025 Mar;31(3):829-839. doi: 10.1038/s41591-024-03475-9. Epub 2025 Mar 4. Nat Med. 2025. PMID: 40038507 Free PMC article.
Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma.
Tschautscher MA, Jevremovic D, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Kapoor P, Dingli D, Hwa L, Fonder A, Hobbs M, Hayman S, Lust J, Russell SJ, Leung N, Go RS, Lin Y, Gonsalves W, Kourelis T, Warsame R, Kyle RA, Vincent Rajkumar S, Kumar S. Tschautscher MA, et al. Among authors: hobbs m. Blood Cancer J. 2020 Oct 2;10(10):95. doi: 10.1038/s41408-020-00363-6. Blood Cancer J. 2020. PMID: 33009363 Free PMC article. No abstract available.
903 results